PROBMET
Probmet is a precision oncology therapeutics company developing treatments for breast cancer and brain metastatic patients. It was founded in 2022 and is headquartered in Copenhagen, Denmark.
PROBMET
Social Links:
Industry:
Health Care Medical Oncology Therapeutics
Founded:
2022-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.probmet.com
Total Employee:
1+
Status:
Active
Total Funding:
500 K EUR
Technology used in webpage:
Hetzner
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NBE-Therapeutics
NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
BioInnovation Institute
BioInnovation Institute investment in Convertible Note - Probmet
Official Site Inspections
http://www.probmet.com
- Host name: dedi2723.your-server.de
- IP address: 78.47.139.154
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Probmet"
Welcome - Probmet
Probmet Therapeutics was established in 2022 in Denmark as a university spin-out from The Royal College of Surgeons in Ireland and is currently incubated at the BioInnovation Institute …See details»
Probmet - Crunchbase Company Profile & Funding
Organization. Probmet . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Probmet is a precision …See details»
Probmet Company Profile 2024: Valuation, Funding & Investors
Probmet General Information Description. Operator of a therapeutics company intended to develop treatments for cancer. The company's platform develops targeted treatments for …See details»
Meet the start-ups: Probmet - BioInnovation Institute
Jul 27, 2022 PrOBMet is a spin-out from the RCSI University of Medicine and Health Sciences that draws on the collaborative expertise of the Beaumont RCSI Cancer Centre. The company …See details»
Probmet - Products, Competitors, Financials, Employees, …
Probmet is a precision oncology therapeutics company focused on developing targeted treatments for breast cancer brain metastasis. The company's main offerings include a peptide …See details»
Probmet - Funding, Financials, Valuation & Investors - Crunchbase
Probmet is a precision oncology therapeutics company developing treatments for cancer. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
Probmet ApS Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Probmet ApS of København N, Hovedstaden. Get the latest business insights from Dun & Bradstreet.See details»
Probmet | DANISH BIO - Dansk Biotek
PrOBMet was established in 2022 in Denmark and is located at the BioInnovation Institute in Copenhagen. Contact name: Aoife Cannon. Address: Ole Maaløes Vej 3. Email: …See details»
Probmet - Crunchbase
Probmet is a precision oncology therapeutics company developing treatments for cancer.See details»
Probmet: Drug pipelines, Patents, Clinical trials - Synapse
Jul 4, 2023 Explore Probmet with its drug pipeline, therapeutic area, technology platform, .See details»
Probmet - Company Profile - Tracxn
Oct 18, 2024 Probmet ranks 33rd among 33 competitors. 7 of its competitors are funded while 6 have exited. Overall, Probmet and its competitors have raised over $757M in funding across …See details»
Highlighting five promising therapeutics start-ups in the life …
Apr 19, 2023 Probmet: PrOBMet is a spin-out from the RCSI University of Medicine and Health Sciences that draws on the collaborative expertise of the Beaumont RCSI Cancer Centre. The …See details»
Probmet Stock Price, Funding, Valuation, Revenue & Financial …
Mar 15, 2022 Probmet has raised $550K over 1 rounds. Probmet's latest funding round was a Convertible Note for $0.55M on March 15, 2022. Date. Round. Amount. Investors. Valuation. …See details»
Royal College of Surgeons in Ireland (RCSI)’s Post - LinkedIn
Meet RCSI’s newest spin-out company: PrOBMet RCSI’s newest spin-out company, PrOBMet, is a precision oncology therapeutics company that is developing targeted…See details»
Probmet - EU-Startups
Probmet is a precision oncology therapeutics company that is creating specialised therapies for people with brain metastases from breast cancer. The group will spearhead the creation of …See details»
Probmet - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Probmet is a precision oncology therapeutics company developing treatments for cancer.See details»
Privacy Policy - Probmet
Probmet BioInnovation Institute Ole Maaløes Vej 3, 2200 Copenhagen, Denmark CVR: 43125397See details»
Preeclampsia and Eclampsia - Preeclampsia and Eclampsia - MSD …
Preeclampsia and eclampsia are major causes of maternal mortality in the Unites States (1) and worldwide (2).Women who have preeclampsia are at risk of placental abruption in the current …See details»
Probmet - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Probmet . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... Probmet has 2 …See details»
ChromEMT: visualizing and reconstructing chromatin ... - Nature
5 days ago ChromEMT is a method that selectively enhances the electron density and contrast of DNA and interacting nucleosome particles, enabling chromatin ultrastructure and 3D …See details»